Apellis Pharmaceuticals buy Sievi
Start price
08.08.23
/
50%
€22.40
Target price
08.09.23
-
Performance (%)
29.46%
End price
21.08.23
€29.00
Summary
This prediction ended on 21.08.23 with a price of €29.00. The prediction had a final performance of 29.46%. Sievi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Apellis Pharmaceuticals | - | - | - |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
According to Sievi what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year